Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122343) titled 'Effects of remazolam on neuroelectrophysiological and cerebral oxygen monitoring during carotid endarterectomy' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Hengshui People's Hospital
Condition:
Moderate to severe carotid artery stenosis
Intervention:
Remimazolam group:Continuous infusion of remimazolam during surgery
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-02-26
Target Sample Size: Remimazolam group:102;Propofol group:102;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308...